Advertisement

Reactions Weekly

, Volume 1777, Issue 1, pp 81–81 | Cite as

Crizotinib

Various fatal toxicities: 76 case reports
Case report
  • 12 Downloads

Reference

  1. Ueno N, et al. Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings. Japanese Journal of Clinical Oncology 49: 676-686, No. 7, Jul 2019. Available from: URL: http://doi.org/10.1093/jjco/hyz049 - JapanCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations